Drug Discovery 2022: driving the next life science revolution
Where: E11 [Show on Floor Plan]
Sengenics is proud to be a sponsor of this year's ELRIG Drug Discovery!

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
Tel: -
Address: 44 Manning Rd
Billerica, MA
Website: https://sengenics.com/
Email: enquiries@sengenics.com

Staff Attending

Dr Tanja Büsgen
Director of Sales - Central Europe
Mr Adrian Churchman
Head of EU &UK